New Delhi: Jaypee Brothers Medical Publishers (2011) pp
This means that the body requires fewer calories to function, which can lead to a slowing of weight loss over time
Overexpression of phosphodiesterase 3B promotes cAMP hydrolysis and reduces GLP-1-induced insulin secretion, an effect evident in both isolated islets and cultured insulinoma cells (Hrndahl et al., 2002)
Missing a dose can affect appetite control and slow progress depending on timing and frequency
These symptoms are typically temporary, and adjusting the dose can be necessary depending on your bodys reaction to the drug
If you're taking semaglutide for weight loss and want to continue obesity treatment, your provider may recommend an alternative weight loss drug like: Tirzepatide (Mounjaro or Zepbound) Liraglutide (Saxenda or Victoza) Metformin Topiramate (Topamax) Depending on why you're discontinuing semaglutide, you may be able to take another GLP-1 weight loss injection, or you could consider oral weight loss treatments